(NASDAQ: CRBU) Caribou Biosciences's forecast annual revenue growth rate of 84.1% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 115.73%, and while it is forecast to beat the US market's average forecast revenue growth rate of 23.06%.
Caribou Biosciences's revenue in 2026 is $9,295,000.On average, 9 Wall Street analysts forecast CRBU's revenue for 2026 to be $978,143,018, with the lowest CRBU revenue forecast at $852,802,379, and the highest CRBU revenue forecast at $1,128,626,559. On average, 7 Wall Street analysts forecast CRBU's revenue for 2027 to be $1,107,689,718, with the lowest CRBU revenue forecast at $861,307,970, and the highest CRBU revenue forecast at $1,472,121,599.
In 2028, CRBU is forecast to generate $6,296,474,380 in revenue, with the lowest revenue forecast at $0 and the highest revenue forecast at $20,217,136,619.